MC2 Therapeutics A/S: Financial statements 2017
CVR: 29526346
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
MC2 Therapeutics A/S (CVR 29526346) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 10,252,025 and a net result of DKK -79,128,188 compared with DKK -40,139,989 the year before. That is an increase of 49.8% compared with the year before. Equity in the 2017 report amounted to DKK 30,872,636. The solvency ratio was 65.4%. The company had 8 employees in the financial year.
- Gross Profit
- DKK 10,252,025
- Profit/Loss
- DKK -79,128,188
- Equity
- DKK 30,872,636
- Total Assets
- DKK 47,188,015
- Employees
- 8
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 10.3 mio. | -79.1 mio. | 30.9 mio. | 8 |
| 2016 | - | 6.8 mio. | -40.1 mio. | 54.4 mio. | 5 |
| 2015 | - | 5.4 mio. | -24.5 mio. | 43.4 mio. | 4 |
| 2014 | - | 5.6 mio. | -19.8 mio. | 35.4 mio. | 4 |
| 2013 | - | 3.5 mio. | -25 mio. | 15.9 mio. | 3 |
Official annual report
Keep an eye on MC2 Therapeutics A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
As of June 20, 2017, Jesper Jørn Lange has joined the board of directors of MC2 Therapeutics A/S.
As of June 20, 2017, Mette Vagner Johannesen has joined the board of directors of MC2 Therapeutics A/S.
As of June 20, 2017, Mads Jørgen Nøhr Clausen has joined the board of directors of MC2 Therapeutics A/S.
As of June 20, 2017, Anders Dahlgaard Hove has joined the board of directors of MC2 Therapeutics A/S.
As of June 20, 2017, Paul Louis Berns has joined the board of directors of MC2 Therapeutics A/S.
On June 20, 2017, the company changed its name from MC2 Therapeutics ApS to MC2 Therapeutics A/S.
MC2 Therapeutics A/S has published its annual report for 2016. Gross profit came to DKK 6,841,876, and the net result was DKK -40,139,989.
About MC2 Therapeutics A/S
MC2 Therapeutics A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2006. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named MC2 Therapeutics ApS and MC2 BIOTEK ApS. The management consists of Trine Ahlgreen. The board consists of Mads Jørgen Nøhr Clausen (chair), Anders Dahlgaard Hove, John Sørensen Haurum and Tomas Dahl Mikkelsen. The company is owned by Alsmark Invest II ApS, MC2 HOLDING ApS and Selskabet af 4. april 2023 ApS. The company has 8 employees (2026). In 2025, the company reported a gross profit of DKK 22,248,504 and a net result of DKK -7,816,954 compared with DKK -53,006,931 the year before. Equity in the 2025 report amounted to DKK -224,478,927.